Library Logo
Normal view MARC view ISBD view

FDA Races to Keep Up with Misleading Drug Ads. Julie Schmit.

by Schmit, Julie; ProQuest Information and Learning Company.
Series: SIRS Enduring Issues 2006Article 74Business. Publisher: USA Today, 2005ISSN: 1522-3191;.Subject(s): Advertising -- Drugs | Pharmaceutical industry | United States Food and Drug Adm | VioxxDDC classification: 050 Summary: "Stop misleading the public. Tell the truth. The FDA is firing that doubled-barreled commandment more often when it spots misleading promotions for prescription drugs, a sign the agency is getting tougher on what the pharmaceutical industry does with the $9 billion a year it spends on marketing to consumers and doctors." (USA TODAY) The article discusses the FDA's tougher enforcement of drug marketing.
Tags from this library: No tags from this library for this title. Add tag(s)
Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Call number Status Date due
Books Books High School - old - to delete
REF SIRS 2006 Business Article 74 (Browse shelf) Available
Browsing High School - old - to delete Shelves Close shelf browser
No cover image available No cover image available No cover image available No cover image available No cover image available No cover image available No cover image available
REF SIRS 2006 Business Article 71 E-Commerce Gets Smarter. REF SIRS 2006 Business Article 72 The Idiot Consumer. REF SIRS 2006 Business Article 73 Why Medical Malpractice Caps Are Wrong. REF SIRS 2006 Business Article 74 FDA Races to Keep Up with Misleading Drug Ads. REF SIRS 2006 Business Article 74 The Big Pill Pitch. REF SIRS 2006 Business Article 74 New Drug Ad Guidelines Unlikely to Satisfy. REF SIRS 2006 Business Article 75 Consumer Vertigo.

Articles Contained in SIRS Enduring Issues 2006.

Originally Published: FDA Races to Keep Up with Misleading Drug Ads, May 30, 2005; pp. n.p..

"Stop misleading the public. Tell the truth. The FDA is firing that doubled-barreled commandment more often when it spots misleading promotions for prescription drugs, a sign the agency is getting tougher on what the pharmaceutical industry does with the $9 billion a year it spends on marketing to consumers and doctors." (USA TODAY) The article discusses the FDA's tougher enforcement of drug marketing.

Records created from non-MARC resource.

There are no comments for this item.

Log in to your account to post a comment.

Powered by Koha